Correlation Between Cocrystal Pharma and Checkpoint Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cocrystal Pharma and Checkpoint Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cocrystal Pharma and Checkpoint Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cocrystal Pharma and Checkpoint Therapeutics, you can compare the effects of market volatilities on Cocrystal Pharma and Checkpoint Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cocrystal Pharma with a short position of Checkpoint Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cocrystal Pharma and Checkpoint Therapeutics.
Diversification Opportunities for Cocrystal Pharma and Checkpoint Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cocrystal and Checkpoint is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Cocrystal Pharma and Checkpoint Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Checkpoint Therapeutics and Cocrystal Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cocrystal Pharma are associated (or correlated) with Checkpoint Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Checkpoint Therapeutics has no effect on the direction of Cocrystal Pharma i.e., Cocrystal Pharma and Checkpoint Therapeutics go up and down completely randomly.
Pair Corralation between Cocrystal Pharma and Checkpoint Therapeutics
Given the investment horizon of 90 days Cocrystal Pharma is expected to generate 1.35 times less return on investment than Checkpoint Therapeutics. In addition to that, Cocrystal Pharma is 1.32 times more volatile than Checkpoint Therapeutics. It trades about 0.07 of its total potential returns per unit of risk. Checkpoint Therapeutics is currently generating about 0.12 per unit of volatility. If you would invest 345.00 in Checkpoint Therapeutics on September 13, 2024 and sell it today you would earn a total of 35.00 from holding Checkpoint Therapeutics or generate 10.14% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cocrystal Pharma vs. Checkpoint Therapeutics
Performance |
Timeline |
Cocrystal Pharma |
Checkpoint Therapeutics |
Cocrystal Pharma and Checkpoint Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cocrystal Pharma and Checkpoint Therapeutics
The main advantage of trading using opposite Cocrystal Pharma and Checkpoint Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cocrystal Pharma position performs unexpectedly, Checkpoint Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will offset losses from the drop in Checkpoint Therapeutics' long position.Cocrystal Pharma vs. RenovoRx | Cocrystal Pharma vs. Tempest Therapeutics | Cocrystal Pharma vs. Ikena Oncology | Cocrystal Pharma vs. Moleculin Biotech |
Checkpoint Therapeutics vs. Mustang Bio | Checkpoint Therapeutics vs. Reviva Pharmaceuticals Holdings | Checkpoint Therapeutics vs. Fortress Biotech Pref | Checkpoint Therapeutics vs. Kodiak Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |